Targeting the Root Cause
Of Multiple Major Diseases
ROS – The Common Cause linking Major Diseases.
Our Compound PrC-210 targets ROS, the Root Cause of Diseases.
Reactive Oxygen Species (ROS) cause oxidative stress - damage DNA, proteins, and lipids in our cell.
Chronic oxidative damage drives disease progression and aging - yet it remains largely unaddressed by today's medicine.
PrC-210 neutralizes ROS before it can reach vital cellular structures and cause disease onset and progression.
ALS, ARS, Transplantation, MS and AD all have ROS-driven pathology.
As of today, there is still no approved therapy that directly protects cells from ROS across multiple diseases.
Amyotrophic Lateral Sclerosis
(ALS)
An irreversible, fatal neurodegenerative disease with no therapy that prevents neuronal death. Current drugs extend life only by a few months and do not directly protect neurons.
PrC-210 demonstrates unprecedented Preclinical Efficacy, slowing Disease Progression and Extending Survival for both Prevention and Treatment.
By protecting neurons from oxidative and metabolic stress, PrC-210 directly prevents the emergence of molecular ALS hallmarks, blocking the subsequent neuronal death and immune activation that arise from mitochondrial and oxidative danger signals.
Acute Radiation Syndrome
(ARS)
Is a severe or lethal illness caused by high dose exposure to ionizing radiation. In an age of nuclear threat, no approved drug can save lives from the lethal radiation of a nuclear strike by counteracting GI-ARS, NV-ARS, or multi-organ ARS.
PrC-210 Offers A Scientifically Complete Pre- and Post- Radiation ARS Solution for Military and Civil Protection.
PrC-210 significantly increases survival in both pre- and post-radiation ARS settings, demonstrating robust prophylactic and therapeutic efficacy across multiple lethal dose exposures. PrC-210 ´s unprecedented efficacy, compared with other radio protector candidates, has been validated by independent research.
Multiple Sclerosis
(MS)
Is a chronic demyelinating disease driven by immune-mediated axonal destruction, with no cure and no neuroprotective therapies.
PrC-210 is the only drug that directly inhibits MS pathology at its source by scavenging ROS produced by activated immune cells, thereby halting disease initiation and progression.
PrC-210 prevents demyelination through directly protecting axons from ROS-mediated damage rather than through secondary indirect immune modulation.
Alzheimer’s Disease
(AD)
An irreversible Progressive Neurodegenerative Disease with no Therapy that protects Neurons and Glia from Degeneration. Most Drugs target downstream or single misfolded Protein Pathways only.
PrC-210 quenches Age-related Oxidative Stress, preventing Mitochondrial Dysfunction, Protein Misfolding, Neuronal Death, and Neuroinflammation across all Stages of AD.
PrC-210 halts the Molecular Hallmarks of Alzheimer’s Disease by protecting Neurons from Oxidative Damage and Metabolic Stress, thereby preventing Neuronal Death and Immune Activation through Mitochondrial and Oxidative Danger Signals.
Transplantation - Ischemia-reperfusion injury
(IRI)
Fewer than 10% of Global Transplant Needs are met, Organ Viability remains limited, and the Risks of Chronic rejection and Graft loss are high, with no Drug available to extend long-term Graft survival.
PrC-210 reduces Ischemic Storage Injury and Kidney Damage to Background Levels while also markedly suppressing Inflammation and Fibrosis.
PrC-210 protects against ROS Injury during both Ischemia and Reperfusion (IRI), reaches all Cellular Compartments including Mitochondria, safeguards Cells from within, and blocks Immune-cell Infiltration and Activation, thereby reducing Organ Damage, GVHD, and Graft Failure.
